Description

11-[2-Methyl-3-[Methyl(Trideuteriomethyl)Amino]Propyl]-5,6-Dihydrobenzo[B][1]Benzazepine-3-Carbaldehyde is a deuterated benzazepine derivative, a sophisticated organic compound of significant interest in advanced pharmaceutical research and development. Its core value lies in its role as a key intermediate or reference standard for the synthesis of novel therapeutic agents, particularly in the fields of neurology and psychiatry. This high-purity compound is essential for researchers and manufacturers engaged in drug discovery, metabolic studies, and the development of deuterated drug candidates, where isotopic labeling is crucial for tracking and enhancing pharmacokinetic properties.

Application

• Pharmaceutical Intermediate: Critical building block for the synthesis of deuterium-labeled active pharmaceutical ingredients (APIs).
• Reference Standard: Used in analytical method development and validation for quality control of deuterated drug substances.
• Metabolic Pathway Tracing: Employed in preclinical and clinical research to study drug metabolism and distribution using mass spectrometry.
• Deuterated Drug Discovery: Serves as a precursor in R&D programs aimed at creating new chemical entities with improved metabolic stability and safety profiles.
• Neurological & Psychiatric Research: Applied in the development of potential therapies targeting benzazepine-related receptors in the central nervous system.
• Isotope Labeling Service: A key material for custom synthesis and contract research organizations (CROs) offering deuterium incorporation services.

Basic Information

Product Name	11-[2-Methyl-3-[Methyl(Trideuteriomethyl)Amino]Propyl]-5,6-Dihydrobenzo[B][1]Benzazepine-3-Carbaldehyde
CAS No.	1794938-94-5
Molecular Formula	C22H27D3N2O
Molecular Weight	341.51 g/mol
Synonyms	11-[2-Methyl-3-[Methyl(Trideuteriomethyl)Amino]Propyl]-5,6-dihydrobenzo[b][1]benzazepine-3-carboxaldehyde; Deuterated Benzazepine Carbaldehyde; (CD3)-Labeled Benzazepine Derivative; 5,6-Dihydro-11-[2-methyl-3-[methyl((2)H3)methyl]amino]propyl]benzo[b][1]benzazepine-3-carbaldehyde; Trideuteriomethyl-labeled Benzazepine Intermediate; 1794938-94-5; Benzazepine-3-carbaldehyde, 11-[2-methyl-3-[methyl(trideuteriomethyl)amino]propyl]-5,6-dihydro-
EINECS	Contact for details

Quality Control

Our high-purity deuterated compounds are manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including NMR (¹H, ¹³C, and ²H), HPLC, and mass spectrometry, to confirm chemical identity, isotopic purity (D-enrichment), and chemical purity. Certificates of Analysis (COA) detailing all specifications are provided with every shipment. We support compliance with cGMP and ICH Q7 guidelines for advanced pharmaceutical intermediates.

Storage

Preserve in a tightly closed container, protected from light. Store at controlled room temperature (15-25°C) or as indicated on the label. This compound is easily oxidized; for long-term storage, consider keeping under an inert atmosphere (argon or nitrogen) in a sealed container. Keep the container tightly closed in a dry and well-ventilated place.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (IR)	Conforms to structure
Identification (NMR)	Conforms to structure (¹H, ¹³C)
Purity (HPLC)	≥ 98.0%
Isotopic Purity (²H NMR / MS)	≥ 98 atom % D
Water Content (KF)	≤ 0.5%
Residual Solvents (GC)	Complies with ICH Q3C

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.